Von dem Buch New Cytokines as Potential Drugs (Progress in Inflammation Research) [Hardcover] haben wir 3 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
![New Cytokines as Potential Drugs (Progress in Inflammation Research) [Hardcover]](https://diebuchsuche.de/c-9783764358839-0.jpg){kind=small}
100%: Sous la direction de: Satwant K. Narula, Sous la direction de: R.L. Coffman: New Cytokines as Potential Drugs (Progress in Inflammation Research) [Hardcover] (ISBN: 9783764358839) in Deutsch, Broschiert.Nur diese Ausgabe anzeigen…
100%: Herausgeber: Satwant K. Narula, Herausgeber: Robert Coffman: New Cytokines as Potential Drugs (Progress in Inflammation Research) (ISBN: 9783034884563) in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
100%: K. Narula, Satwant; Coffman, Robert and Narula, Satwant K.: New Cytokines as Potential Drugs (Progress in Inflammation Research) (ISBN: 9783034895750) 2012, in Deutsch, Taschenbuch.Nur diese Ausgabe anzeigen…
New Cytokines as Potential Drugs (Progress in Inflammation Research) [Hardcover]
12 Angebote vergleichen
| Preise | 2012 | 2013 | 2014 |
|---|---|---|---|
| Schnitt | Fr. 110.65 (€ 113.05)¹ | Fr. 66.94 (€ 68.40)¹ | Fr. 140.76 (€ 143.82)¹ |
| Nachfrage |
1
New Cytokines as Potential Drugs
~EN NW EB DLISBN: 9783034884563 bzw. 3034884567, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.
Lieferung aus: Österreich, Lagernd, zzgl. Versandkosten.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... eBook.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... eBook.
2
New Cytokines as Potential Drugs
~EN NW EB DLISBN: 9783034884563 bzw. 3034884567, vermutlich in Englisch, Birkhauser Basel, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
New Cytokines as Potential Drugs: Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Englisch, Ebook.
New Cytokines as Potential Drugs: Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Englisch, Ebook.
3
New Cytokines as Potential Drugs (Progress in Inflammation Research) (2000)
EN NW FE EB DLISBN: 9783034884563 bzw. 3034884567, in Englisch, 141 Seiten, Birkhäuser, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 1st, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2000-03-15, Freigegeben: 1999-12-31, Studio: Birkhäuser.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 1st, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2000-03-15, Freigegeben: 1999-12-31, Studio: Birkhäuser.
4
New Cytokines as Potential Drugs (Progress in Inflammation Research) (2000)
EN NW FE EB DLISBN: 9783034884563 bzw. 3034884567, in Englisch, 141 Seiten, Birkhäuser, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, E-Book zum Download.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 1st, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2000-03-15, Freigegeben: 1999-12-31, Studio: Birkhäuser.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 1st, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2000-03-15, Freigegeben: 1999-12-31, Studio: Birkhäuser.
5
New Cytokines as Potential Drugs (Progress in Inflammation Research) (2012)
EN NW EB DLISBN: 9783034884563 bzw. 3034884567, in Englisch, 153 Seiten, 2000. Ausgabe, Birkhäuser, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download, Versandkostenfrei.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 2000, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2012-11-19, Freigegeben: 2012-11-19, Studio: Birkhäuser.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide... Kindle Edition, Ausgabe: 2000, Format: Kindle eBook, Label: Birkhäuser, Birkhäuser, Produktgruppe: eBooks, Publiziert: 2012-11-19, Freigegeben: 2012-11-19, Studio: Birkhäuser.
6
New Cytokines as Potential Drugs (2012)
EN NW EB DLISBN: 9783034884563 bzw. 3034884567, in Englisch, Birkhäuser, Birkhäuser, Birkhäuser, neu, E-Book, elektronischer Download.
Lieferung aus: Australien, in-stock.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in.
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in.
7
Symbolbild
New Cytokines as Potential Drugs (2000)
DE NWISBN: 9783764358839 bzw. 3764358831, in Deutsch, Springer Basel Ag Feb 2000, neu.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, NDS, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Symbolbild
New Cytokines as Potential Drugs (2014)
DE NWISBN: 9783764358839 bzw. 3764358831, in Deutsch, Springer Basel AG, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Rhein-Team Lörrach, [3332481].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Rhein-Team Lörrach, [3332481].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Symbolbild
New Cytokines as Potential Drugs
DE NWISBN: 9783764358839 bzw. 3764358831, in Deutsch, Springer Basel AG, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Buchhandlung Kühn GmbH, [4368407].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Buchhandlung Kühn GmbH, [4368407].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
New Cytokines as Potential Drugs (Progress in Inflammation Research Series) (2000)
DE HC USISBN: 9783764358839 bzw. 3764358831, in Deutsch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, gebundenes Buch, gebraucht.
Von Händler/Antiquariat, The Book Exchange [3938380], Macclesfield, CHES., United Kingdom.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…